Example: Heart Attack

Search clinical trials for: Entacapone

Total 35 results

NCT04246437

Recruiting

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Conditions: Autonomic Failure, Pure Autonomic Failure, Parkinson Disease, Multiple System Atrophy, Dementia With Lewy Bodies
NCT00262470

Active, not recruiting

Treatment of Orthostatic Intolerance

Conditions: Tachycardia, Chronic Orthostatic Intolerance
NCT02058966

Completed

Pilot Study of Entacapone for Methamphetamine Abuse

Conditions: Methamphetamine Dependence
NCT04006769

Not yet recruiting

Entacapone Combination With Imatinib for Treatment of GIST

Conditions: Gastrointestinal Stromal Tumor, Malignant
NCT01468012

Completed

Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence

Conditions: Cocaine Dependence
NCT01437293

Completed

Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)

Conditions: Cocaine Abuse
NCT00134966

Completed

A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa

Conditions: Parkinson's Disease
NCT00219284

Completed

Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

Conditions: Parkinson's Disease With End of Dose Wearing Off
NCT00143026

Completed

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

Conditions: Parkinson's Disease
NCT00237263

Completed

An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States

Conditions: Parkinson's Disease
NCT02170376

Completed

The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics

Conditions: Parkinson's Disease (PD)
NCT02554734

Completed

Pharmacokinetic Study in Healthy Volunteers

Conditions: Parkinson's Disease
NCT01568073

Completed

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon

Conditions: Parkinson's Disease
NCT01519284

Completed

Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic

Conditions: Parkinson Disease
NCT01840423

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers

Conditions: Healthy
NCT02349243

Unknown status

Effect of Entacapone on Bodyweight Loss in Obese Population

Conditions: Obesity
NCT01688089

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers

Conditions: Healthy
NCT00547911

Terminated

Augmenting Effects of L-DOPS With Carbidopa and Entacapone

Conditions: Parkinson Disease, Multiple System Atrophy, Autonomic Nervous System Diseases
NCT00601978

Withdrawn

Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

Conditions: Parkinson's Disease
NCT00099268

Completed

Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy

Conditions: Parkinson's Disease
NCT00491998

Completed

PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets

Conditions: Parkinson's Disease
NCT00391898

Completed

Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off

Conditions: Parkinson's Disease
NCT00642356

Terminated

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

Conditions: Parkinson's Disease
NCT00192855

Completed

Entacapone Augmentation for Schizophrenia

Conditions: Schizophrenia
NCT01070628

Completed

Levodopa Concentration Profile With Stalevo 75/125 mg

Conditions: Parkinson's Disease